Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX   US5288721047

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
0.9459(c) 0.9325(c) 0.9375(c) 0.9431(c) 0.94(c) Last
1 513 934 1 158 678 2 178 360 6 132 845 931 102 Volume
+1.71% -1.42% +0.54% +0.60% -0.33% Change
More quotes
Company
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease.The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
Sector
Biotechnology & Medical Research
Calendar
03/03 | 08:40amPresentation
More about the company
Surperformance© ratings of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Chart LEXICON PHARMACEUTICALS, I
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 13,5 M
EBIT 2014 -103 M
Net income 2014 -107 M
Debt 2014 -
Yield 2014 -
Sales 2015 15,0 M
EBIT 2015 -109 M
Net income 2015 -122 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 50,6x
Capi. / Sales 2015 45,4x
Capitalization 681 M
More Financials
Latest news on LEXICON PHARMACEUTICALS, I
02/26 LEXICON PHARMACEUTICALS : To Present At The Cowen 35th Annual Health Care Confer..
02/23 LEXICON PHARMACEUTICALS : Announces Management Change
02/20 LEXICON PHARMACEUTICALS : To Present At The BIO CEO & Investor Conference
02/06 LEXICON PHARMACEUTICALS : To Present At The BIO CEO & Investor Conference
02/06 LEXICON PHARMACEUTICALS : Assigned Patent
02/02 LEXICON PHARMACEUTICALS : Stifel Nicolaus Rating Disclosure on Lexicon Pharmaceu..
01/14 LEXICON PHARMACEUTICALS : To Present At The 33rd Annual J.P. Morgan Healthcare C..
01/07 LEXICON PHARMACEUTICALS : To Present At The 33rd Annual J.P. Morgan Healthcare C..
More news
Sector news Bio Therapeutic Drugs
02/27 PHARMACYCLICS : Provides Clinical Update on BTK Inhibitor for Autoimmune Disease..
02/27 ISIS PHARMACEUTICALS : beats Street 4Q forecasts
02/27 ISIS PHARMACEUTICALS : Reports Positive Phase 1 Data Demonstrating ISIS-PKK Rx P..
Plus d'actualités du secteur Bio Therapeutic Drugs


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF